Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02782806 · ClinicalTrials.gov registry record · NA
Spot-Check Noninvasive Pulse CO-Oximeter Validation
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 368
- Enrollment target
NCT02782806 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 368 participants.
The verdict
NCT02782806, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
Study Summary
In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
Interventions
- DEVICE Masimo Rad-67 Pulse Oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2016-04-11 |
| Est. Completion | 2016-05-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02782806
The ClinicalTrials.gov registry entry for NCT02782806 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo Rad-67 Pulse Oximeter is the first listed.
NCT02782806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02782806 about?
NCT02782806 is a clinical study titled "Spot-Check Noninvasive Pulse CO-Oximeter Validation". In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
What is the current status of trial NCT02782806?
This trial is currently completed. It is a NA study. The enrollment target is 368 participants. The study started on 2016-04-11. Estimated completion is 2016-05-19.
What interventions are being tested in trial NCT02782806?
The interventions under investigation include: Masimo Rad-67 Pulse Oximeter (DEVICE).
Who is sponsoring clinical trial NCT02782806?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.